
|Articles|October 15, 2012
Screening for those at high risk for T2DM does not reduce mortality within 10 years, study finds
Screening patients who are at high risk for diabetes does not reduce their all-cause, cardiovascular, or diabetes-related mortality within 10 years, according to a study published Oct. 4 in The Lancet
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Coming Full Circle: How Mike Brundage Built a Thriving Pharmacy in Rural Pennsylvania
2
Severe COVID-19 Increases Stroke Risk for Patients With Asthma
3
FDA Approves First 1-Minute Self Test for HIV
4
Pharmacists Help Patients Stay Adherent to COPD Therapy, Improving Overall Quality of Life
5